Frequency of Dyslipidemia in Male Patients of Androgenetic Alopecia
Keywords:
Androgenetic Alopecia, Deranged Blood Lipids, Serum Cholesterol, Triglycerides, LDL-C, HDL-C.Abstract
Background: Among prevalent forms of non-scarring alopecia is androgenetic alopecia (AGA), triggered by androgens, causing gradual, symmetrical hair loss in genetically predisposed individuals. Blood lipids (BDL) in the bloodstream can be free or bound to other molecules, with the research focusing on abnormal levels in men with AGA to explore their potential link to the condition. Objective: The present study aimed to determine the frequency of dyslipidemia in male patients with androgenetic alopecia (AGA) and its potential association with abnormal lipid profile. Methods: The research was carried out at Department of Dermatology Unit-I, Jinnah Hospital Lahore from July 20, 2020 to Jan 20, 2021. A total of 150 patients meeting the selection criteria were chosen for the study. Fasting blood samples were collected for lipid profile analysis (following a fasting period of 9 to 12 hours). The lipid profile analysis was performed at the same laboratory. Factors such as age, BMI, type of hair loss, and duration of alopecia were recorded using a predefined form. Results: The mean age of patients was 35.01±8.29 years. The mean serum cholesterol was 211.31±37.04, the mean triglycerides was 195.60±54.95, the mean low density lipoprotein cholesterol (LDL-C) was 155.05±56.50 and mean high-density lipoprotein cholesterol HDL-C was 55.94±16.50. There were 94(62.7%) cases who had deranged blood lipids and 56(37.3%) had normal lipid profile. Conclusion: A high percentage of male androgenetic alopecia cases, around 62.7%, showed abnormal blood lipid levels. Assessing lipids in these individuals is crucial for early detection of cardiovascular and metabolic risks, that will help in improving health outcomes.References
Swaroop MR, Kumar BM, Sathyanarayana BD, Yogesh D, Raghavendra JC, Kumari P. The Association of Metabolic Syndrome and Insulin Resistance in Early-Onset Androgenetic Alopecia in Males: A Case-Control Study. Indian J Der-matol. 2019;64(1):23-7.
Sheikh FZ, Butt G, Hafeez R, Maqsood A, Altaf F, Hussain I. Association of Early-onset Andro-genetic Alopecia and Metabolic Syndrome. J Coll Physicians Surg Pak. 2021;31(02):123-127.
Oiwoh SO, Enitan AO, Adegbosin OT, Akinboro AO, Onayemi EO. Androgenetic alopecia: A review. Nigerian Postgraduate Med J. 2024;31(2): 85-92.
Kamishima T, Hirabe C, Myint KZ, Taguchi J. Divergent progression pathways in male andro-genetic alopecia and female pattern hair loss: Trichoscopic perspectives. J Cosmetic Dermatol. 2024;23(5):1828-39.
Hedayatnia M, Asadi Z, Zare-Feyzabadi R, Yaghooti-Khorasani M, Ghazizadeh H, Ghaffa-rian-Zirak R, et al. Dyslipidemia and cardiovas-cular disease risk among the MASHAD study population. Lipids Health Dis. 2020;19(1):020-01204.
Dharam Kumar KC, Kishan Kumar YH, Neladimmanahally V. Association of Androge-netic Alopecia with Metabolic Syndrome: A case-control Study on 100 Patients in a Tertiary Care Hospital in South India. Indian J Endocrinol Metab. 2018;22(2):196-9.
Qazi I, Tilwani MR, Nabi N. Association of Dyslipidemia and Androgenetic Alopecia: A Case Control Study. Int J Cont Med Res. 2019;6(7):32-5.
Bilquees D, Akbar N, Fatima K. Frequency of deranged blood lipids in male patients with androgenetic alopecia. J Pak Assoc Dermatol.2019;28(4):406-9.
Fortes C, Mastroeni S, Mannooranparampil TJ, Ribuffo M. The combination of overweight and smoking increases the severity of androgenetic alopecia. Int J Dermatol. 2017;56(8):862-7.
James M, Varghese TP, Sharma R, Chand S. Association between metabolic syndrome and diabetes mellitus according to International Dia-betic Federation and National Cholesterol Edu-cation Program Adult Treatment Panel III criteria: a Cross-sectional study. J Diabetes Metabol Disorders. 2020;19(1):437-43.
Ak?n T, Kutlubay Z, A?k?n Ö. The Comparison of Blood Lipid Profile in Patients with and Without Androgenetic Alopecia. J Turk Acad Dermatol. 2020;14(1):12.
Qazi I, Tilwani MR, Nabi N. Association of Dyslipidemia and Androgenetic Alopecia: A Case Control Study. Int J Contemp Med Res. 2019.
Arias-Santiago S, Gutiérrez-Salmerón MT, Buen-dia-Eisman A, Giron-Prieto MS, Naranjo-Sintes R. A comparative study of dyslipidaemia in men and women with androgenic alopecia. Acta Derm Venereol. 2010;90(5):485-7.
